David L. Bartlett

发表

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy

Zuqiang Liu, Z. Guo, Zhi Zhu, 2022, Biomedicines.

Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity

J. Luketich, A. Donnenberg, V. Donnenberg, 2022, Frontiers in Immunology.

Epitope‐optimized alpha‐fetoprotein genetic vaccines prevent carcinogen‐induced murine autochthonous hepatocellular carcinoma

D. Munn, L. Butterfield, Z. Guo, 2014, Hepatology.

Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy

M. Lotze, Zuqiang Liu, R. Ravindranathan, 2020, Cancer Gene Therapy.

361 Universal expansion of CBL-B-inhibited tumor infiltrating lymphocytes, DeTIL-0255, from women with ovarian cancer: Process validation

M. Lotze, E. Wang, J. Chapman, 2022, Regular and Young Investigator Award Abstracts.

A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells

J. Luketich, A. Donnenberg, V. Donnenberg, 2023, Frontiers in Immunology.

1435 Comparison of the cytokine and chemokine secretome of benign and malignant peritoneal fluid identifies FGF and IL 1R alpha as potential drivers of tumor growth

A. Donnenberg, V. Donnenberg, David L. Bartlett, 2022, Regular and Young Investigator Award Abstracts.

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy

Z. Guo, D. Bartlett, Zuqiang Liu, 2017, Nature Communications.

Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.

Z. Guo, D. Bartlett, S. Thorne, 2008, Biochimica et biophysica acta.

Diagnosis of T-cell-mediated kidney rejection by biopsy-based proteomic biomarkers and machine learning

Xia Li, P. Wagner, K. Xiao, 2023, Frontiers in Immunology.